ISIN | LU2404422649 |
---|---|
Valorennummer | 115548525 |
Bloomberg Global ID | WEHCESA LX |
Fondsname | Wellington Management Funds (Luxembourg) III SICAV - Wellington Emerging Markets Health Care Equity Fund USD S AccU |
Fondsanbieter |
Wellington Management Company LLP
Web: https://www.wellingtonfunds.com |
Fondsanbieter | Wellington Management Company LLP |
Vertreter in der Schweiz |
BNP Paribas, Paris, Zurich Branch Zürich |
Distributor(en) |
Wellington Global Administrator Ltd. Hamilton |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | Equity Health Care |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | Kombination von Ausgabekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Konditionen bei der Rücknahme | Kombination von Rücknahmekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Investment-Strategie *** | The investment objective of the Fund is to seek long-term total returns in excess of the S&P BMI Emerging Markets Health Care Index (the "Index"), primarily investing in health care companies that are located in and/or conduct substantial business in emerging market countries, inclusive of frontier market countries (as defined by MSCI). |
Besonderheiten |
Aktueller Preis * | 7.61 USD | 21.11.2024 |
---|---|---|
Vorheriger Preis * | 7.65 USD | 20.11.2024 |
52 Wochen Hoch * | 8.40 USD | 04.10.2024 |
52 Wochen Tief * | 6.74 USD | 18.04.2024 |
NAV * | 7.61 USD | 21.11.2024 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 879'117 | |
Anteilsklassevermögen *** | 791'172 | |
Trading Information SIX |
YTD-Performance | - | - |
---|---|---|
YTD-Performance (in CHF) | - | - |
1 Monat | -5.70% |
21.10.2024 - 21.11.2024
21.10.2024 21.11.2024 |
3 Monate | +0.37% |
21.08.2024 - 21.11.2024
21.08.2024 21.11.2024 |
6 Monate | +2.73% |
21.05.2024 - 21.11.2024
21.05.2024 21.11.2024 |
1 Jahr | +5.29% |
20.02.2024 - 21.11.2024
20.02.2024 21.11.2024 |
2 Jahre | +5.29% |
20.02.2024 - 21.11.2024
20.02.2024 21.11.2024 |
3 Jahre | -23.95% |
16.12.2021 - 21.11.2024
16.12.2021 21.11.2024 |
5 Jahre | - | - |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Apollo Hospitals Enterprise Ltd | 6.26% | |
---|---|---|
Innovent Biologics Inc | 4.96% | |
IHH Healthcare Bhd | 4.44% | |
Torrent Pharmaceuticals Ltd | 4.40% | |
Jiangsu Hengrui Pharmaceuticals Co Ltd Class A | 4.21% | |
Cipla Ltd | 3.97% | |
Hapvida Participacoes Investimento SA Ordinary Shares | 3.59% | |
Fortis Healthcare Ltd | 3.58% | |
Genomma Lab Internacional SAB de CV Class B | 3.42% | |
Sino Biopharmaceutical Ltd | 3.25% | |
Letzte Daten-Aktualisierung | 30.09.2024 |
TER | |
---|---|
Datum TER | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.10% |
Ongoing Charges *** | 1.30% |
SRRI ***
|
|
Datum SRRI *** | 31.07.2022 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |